학술논문

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
Document Type
Article
Source
In: International Journal of Dermatology. (International Journal of Dermatology, April 2024, 63(4):503-511)
Subject
Language
English
ISSN
13654632
00119059